drugset / Trial / NCT02180880

Symptom Based Treatment of Neuropathic Pain

NCT02180880

Phase 4 Completed 63 enrolled Ju Seok Ryu
NaSingle-groupOpen-labelTreatment

Summary

1\. Neuropathic pain in spinal cord injured patients 1. Inclusion criteria * pain intensity, visual analogue scale \> 3 * a LANSS (Leeds assessment of neuropathic symptoms and signs) score of 12 and above * aged ≥20 2. Method * Stop pain medications * Test oxcarbazepine (150mg twice daily) and pregabalin (150mg twice daily) * Check pain intensity (VAS score) with Baron's classification

Timeline

Start
2012-11
Primary completion
2014-08
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxcarbazepine Small molecule 150 mg
Subject Pregabalin Small molecule 150 mg